Pharmadax Inc. Announces Seroquel XR® Patent Challenge Settlement

Pharmadax Inc. has entered into a licensing agreement with AstraZeneca Pharmaceuticals concerning its generic version of Seroquel XR® (quetiapine fumarate extended-release) tablets(PRWeb February 15, 2015)Read the full story at http://www.prweb.com/releases/2015/02/prweb12518947.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news